tiprankstipranks
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE
US Market
RARE
Ultragenyx Pharmaceutical
RESEARCH TOOLSreports

Ultragenyx Pharmaceutical (RARE) Cash flow

1,216 Followers

Ultragenyx Pharmaceutical Cash Flow

RARE's free cash flow for Q4 2025 was $-100.77M. For the 2025 fiscal year, RARE's free cash flow was decreased by $-50.32M and operating cash flow was $-99.83M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -466.00M$ -414.19M$ -474.81M$ -380.46M$ -338.69M
Investing Cash Flow
$ 236.00M$ -17.77M$ 168.00M$ -291.65M$ -195.37M
Financing Cash Flow
$ 478.00M$ 399.24M$ 388.14M$ 501.21M$ 118.55M
End Cash Position
$ 436.00M$ 184.16M$ 219.40M$ 137.60M$ 309.58M
Free Cash Flow
$ -472.00M$ -421.68M$ -521.57M$ -526.59M$ -411.79M
Currency in USD

Ultragenyx Pharmaceutical Cash Flow